TGFB1 and Hepatic fibrosis: These data support the elegant studies by Henderson et al. which demonstrated that HSC-specific targeted deletion of αV, but not global lack of β3, β5 or β6, or HSC-specific deletion of β8, protects from CCl4-induced liver fibrosis [97] due to a significant drop in the level of active TGFβ.